UPDATE!!! UPDATE!!! Want to make sure that your members of Congress get the message that the U.S. drug war fuels Mexican violence? Then check out my commentary today in The Hill — Congress’ insider newspaper and website. Read my commentary here, and please leave feedback on their board. Your members of Congress will see it, I promise.
It was less than one year ago when acting U.S. DEA administrator Michelle Leonhart publicly declared that the escalating violence on the U.S./Mexico border should be viewed as a sign of the “success” of America’s drug war strategies.
“Our view is that the violence we have been seeing is a signpost of the success our very courageous Mexican counterparts are having,” said Michele Leonhart, who was recently nominated by President Obama to be the agency’s full time director. “The cartels are acting out like caged animals, because they are caged animals.”
To rest of us, however, these acts are nothing short of a senseless tragedy — a tragedy made all that much more heart-wrenching because it is U.S. policy that is helping to fuel this violence.
Wire-service reports estimate that Mexico’s drug lords employ over 100,000 soldiers — approximately as many as the Mexican army — and that the cartels’ wealth, intimidation, and influence extend to the highest echelons of law enforcement and government. Where do the cartels get their unprecedented wealth and power? By trafficking in illicit drugs — primarily marijuana — over the border into the United States.
The U.S. Office of National Drug Control Policy … says that more than 60 percent of the profits reaped by Mexican drug lords are derived from the exportation and sale of cannabis to the American market. … (By comparison, only about 28 percent of their profits are derived from the distribution of cocaine, and less than 1 percent comes from trafficking methamphetamine.) … Government officials estimate that approximately half the marijuana consumed in the United States originates from outside its borders, and they have identified Mexico as far and away America’s largest pot provider.
If the Obama administration wishes to once and for all reduce this unprecedented wave of Mexican drug-gang violence, then it needs to remove the drug lord’s primary source of income — and that’s marijuana trafficking.
According to a 2007 economic assessment, U.S. citizens spend $113 billion dollars annually to consume an estimated 31.1 million pounds of pot. According to the federal government, over 100 million Americans have used marijuana; over one in ten Americans do so regularly. In short, criminal marijuana prohibition does not, and will not, reduce demand. So then it’s time to regulate the supply.
It is time to remove the production and distribution of marijuana out of the hands of violent criminal enterprises and into the hands of licensed businesses, and the only way to do that is through legalization.
On Monday I joined Judge Andrew Napolitano on FoxNews.com to discuss how marijuana legalization — not increasing levels of government prohibition — would quell the violence surrounding the trafficking of Mexican marijuana. You can watch the video here.
The Judge ‘gets it;’ let’s hope that the administration will one day ‘get it’ too.
To the surprise of virtually no one who has been following public opinion polls for the past 18 months, the call to “legalize the medicinal and recreational use of marijuana” placed #1 in the 2010 Change.org online vote for the “Top 10 Ideas for Change in America.”
Yet despite these consistent first-place finishes, the administration and the mainstream media remain dismissive. President Obama has twice publicly retreated from the issue — the second time chuckling that such a question would even be asked of him. His press secretary discounted the issue’s true public support, claiming that groups like NORML had somehow stuffed the online ballot box. As if! Meanwhile, mainstream media outlets brushed off the results as the work of “Internet trolls.”
Will today’s latest poll results finally be the time that President Obama, his press secretary, stuttering Robert Gibbs, Drug Czar Gil ‘legalization isn’t in my vocabulary‘ Kerlikowske, and the members of the mainstream press start to heed the public’s message that marijuana legalization is not a political liability, but rather it is a political opportunity?
It’s the ‘Catch-22’ that has plagued medical marijuana advocates and patients for decades. Lawmakers and health regulators demand clinical studies on the safety and efficacy of medical cannabis, but the federal agency in charge of such research bars these investigations from ever taking place.
But it took until now for the federal government to finally admit it.
A spokesperson for the U.S. National Institute on Drug Abuse (NIDA) told The New York Times last week that the agency does “not fund research focused on the potential medical benefits of marijuana.”
Why is this admission so significant? Here’s why.
Under federal law, NIDA (along with the U.S. Drug Enforcement Administration) must approve all clinical and preclinical research involving marijuana. NIDA strictly controls which investigators are allowed access to the federal government’s lone research supply of pot – which is authorized via a NIDA contract and cultivated and stored at the University of Mississippi.
In short, no NIDA approval = no marijuana = no scientific studies. And that is, and always has been, the problem.
But to the folks over at NIDA, there’s no problem at all.
Speaking to The New York Times in a January 19, 2010 article entitled, “Researchers Find Medical Study of Marijuana Discouraged,” NIDA spokeswoman Shirley Simson said: “As the National Institute on Drug Abuse, our focus is primarily on the negative consequences of marijuana use. We generally do not fund research focused on the potential beneficial medical effects of marijuana.”
Since NIDA presently oversees an estimated 85 percent of the world’s research on controlled substances, the agency’s ban on medical marijuana research isn’t just limited to the United States’ borders; it extends throughout the planet.
Previous legal attempts to break NIDA’s bureaucratic logjam have failed to weaken the agency’s iron grip.
In 2007, U.S. DEA Administrative Law Judge Mary Ellen Bittner ruled that NIDA’s monopolization of marijuana research is not “in the public interest,” and ordered the federal government to allow private manufacturers to produce the drug for research purposes. But in January of last year, DEA Deputy Administrator Michele Leonhart set aside Judge Bittner’s ruling – stating that NIDA possesses “adequate” quantities of cannabis to meet the needs of clinical investigators, and that the agency monopoly on the distribution of marijuana for research is compliant with America’s international treaty obligations. (Notably, on January 26, 2010 President Barack Obama selected Leonhart to be the DEA’s full time Director.)
Most recently, in November 2009 the American Medical Association’s (AMA) Council on Science and Public Health declared, “Results of short term controlled trials indicate that smoked cannabis reduces neuropathic pain, improves appetite and caloric intake especially in patients with reduced muscle mass, and may relieve spasticity and pain in patients with multiple sclerosis.”
However, the Council lamented that despite these encouraging preliminary results, “[T]here is a contrast between the relatively small number of patients who have been studied over the past 30 years in controlled clinical trials involving smoked cannabis and survey data from patients with chronic pain, multiple sclerosis, and amyotrophic lateral sclerosis that indicates a significant use of cannabis for self management.”
And just what is the precise reason for this “contrast?” The AMA failed to specify, but to anyone who has followed this issue, the answer is painfully obvious.
Nevertheless, the AMA still resolved, “[The] AMA urges that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines.”
But since any future clinical trials would still require NIDA approval — approval that the agency admits won’t be coming any time soon — it remains unclear what effect, if any, the AMA’s declaration will have on facilitating medical marijuana research. If history is any guide, it’s unlikely that the AMA request — much like the cries of tens of thousands of patients before it — will have any effect on NIDA at all.
[FYI... You can also comment on this essay on Alternet.org's newly launched SpeakEasy blog here or on the Huffington Post here.]
Of all of America’s Founding Fathers, only Benjamin Franklin was a signer of all three of our country’s essential documents, The Declaration of Independence, the Treaty that ended the Revolutionary War and the United States Constitution. Benjamin Franklin was also the only Founding Father who actively campaigned against the institution of slavery. As a scientist, Benjamin Franklin, the man who learned to control lightning, was as revered and world-famous in his day, as Einstein was in his. Franklin, among many other things, gave us the conceptual framework we still use every time we think about things electrical. He was the first to describe electricity as having positive and negative charges. Ben Franklin’s fingerprints are everywhere one looks in 21st Century.
Ben Franklin has often been called “the first American”, because, in so many ways, he embodied the brash new nation he helped create. His talents as an inventor and scientist are legendary. Consider a few of the useful creations that Ben left us: bifocal glasses, the wood stove and the lightning rod. They were all inventions he chose not to patent because he saw they were so potentially useful to the general public. They were among his many gifts to humanity. As the statesman, Ben Franklin was as essential to creating our new nation, as was George Washington, the soldier. Franklin’s unique combination of charm, celebrity and brilliance brought France in on our side of the Revolutionary War with the troops, navy and money necessary for us to win. As a proud citizen of a free society, Ben’s genius also flourished with his social inventions like the volunteer fire department, the lending library, the community hospital and, what has become, the University of Pennsylvania. As a writer, his prime work is The Autobiography of Benjamin Franklin, a bestseller, never out of print since it was written, nearly 250 years ago. It is the true story of a runaway printer’s apprentice who, at the age of 17, stole himself from his older brother to whom he was indentured until he was 21 years old. Franklin’s Autobiography is the original blueprint to the ‘American Dream’ of how to become a self-made man. Horatio Alger and Dale Carnegie, are simply Ben’s 19th and 20th Century adherents and proselytizers. Today in the 21st Century, self-help books cover whole walls in bookshops. Franklin was the author the world’s very first best-selling book in the self-help genre.
I made a few comments at NORML’s National Conference at the 2008 conference about why I believe that NORML is a legitimate offspring of Ben Franklin’s social genius. On my flight home, I looked out the airplane window and I saw Ben waving back at me.
Help Support NORML’s End of Year Drive – Donate Now
Dear NORML Supporter:
It is not often that I feel compelled to write to NORML’s membership and supporters regarding the day-to-day operations of America’s leading marijuana lobby group. Then again, in my tenure as Executive Director of NORML and the NORML Foundation, there’s never been a time like right now.
Over the past several months NORML’s public prominence and political influence has grown by leaps and bounds. As I write you today I’m reflecting upon two of the most significant – and productive – weeks in NORML history. As we close the year 2009 I am proud to say that NORML has galvanized its position as the leading marijuana law reform organization. Why do I say this? Take a look at the events of these two weeks late this fall, and decide for yourself:
Marijuana legalization in Massachusetts? NORML testifies ‘Yes!’
On Wednesday, October 14, NORML’s Legal Counsel Keith Stroup and NORML Advisory Board Member Dr. Lester Grinspoon testified before the Massachusetts Joint Committee on Revenue in favor of House Bill 2929, ‘An Act to Regulate and Tax the Cannabis Industry.’ Members of NORML’s state affiliate, MassCann, also spoke on behalf of the measure, which was drafted by former NORML Board Member Richard Evans. The well-attended legislative hearing marked the first time that Massachusetts state legislators had ever publicly discussed legalizing marijuana, and the debate earned prominent media coverage throughout the state.
California Governor Arnold Schwarzenegger requests marijuana legalization debate
In May Gov. Arnold Schwarzenegger publicly called for a debate on the merits of marijuana regulation. This October NORML Deputy Director Paul Armentano and CalNORML Coordinator Dale Gieringer obliged the Governor’s request, and provided his office with a comprehensive action plan for regulating marijuana production and distribution in California.
Obama to Justice Department: Back off on medi-pot prosecutions On Monday, October 19, U.S. Deputy Attorney General David Ogden issued a historic memorandum to federal prosecutors advising them to no longer "focus federal resources … [on those] whose actions are in … compliance with existing state laws providing for the medical use of marijuana." The directive upheld a campaign promise by President Obama, who had pledged that he would not use "Justice Department resources to try to circumvent state laws." Ever since the President took office NORML and other drug policy reform groups had lobbied the administration to follow through, in writing, with this sensible policy. Tellingly, the administration’s decision was hailed by the mainstream media as a major step toward the enactment of marijuana liberalization in America. Not surprisingly, NORML representatives spent the days immediately following the administration’s announcement speaking with dozens of mainstream media outlets, including CNN, MSNBC, The Associated Press, and The Christian Science Monitor, urging Congress to move expeditiously to make the administration’s policy changes into permanent law.
Mainstream media just can’t get enough pot
Over the past month NORML has fielded multiple requests from producers at mainstream media, radio, and television outlets throughout the nation and the world. Notably, NORML’s staff participated in the production of Fox Business News weeklong series on the cannabis industry (air date October 19-23), Newsweek’s five-part series on present and past marijuana policy (published October 16), and the October 14 edition of PBS’ News Hour with Jim Leher. NORML has also recently received prominent coverage in periodicals such as the BBC, The Wall Street Journal, and Fortune Magazine. Unlike in past years – or even past months – the overall tone of all of these high profile features was favorable to marijuana law reform. The underlying media message: marijuana is a commodity, not a moral threat, and it’s about time for America’s laws to start treating it that way.
The Drug Czar’s office comes calling
On Monday, October 24 – at the request of the White House – I participated in a strategic conference call with Drug Czar Gil Kerlikowske to discuss the drafting of the administration’s 2010 National Drug Control Strategy. You read that right: the Office of National Drug Control Policy reached out to NORML and requested NORML’s participation in crafting the administration’s future drug reform strategies. Yes, the same office that just one year ago inflicted the cannabis community with John Walters is now making house calls to NORML.
My friends, the times are most definitely changing.
NORML testifies at California Assembly hearings on legalization
Finally, to conclude two of my busiest weeks ever as NORML and NORML Foundation Director, on Wednesday, October 28, NORML’s Paul Armentano and Dale Gieringer traveled to Sacramento to testify before the California Assembly on Public Safety to urge legislators to stop arresting responsible marijuana smokers. "The criminal prohibition of marijuana has not dissuaded anyone from using marijuana or reduced its availability; however, the strict enforcement of this policy has adversely impacted the lives and careers of millions of people who simply elected to use a substance to relax that is objectively safer than alcohol," Armentano told the Committee. "NORML believes that the state of California ought to amend criminal prohibition and replace it with a system of legalization, taxation, regulation, and education." Like in Massachusetts two weeks earlier, the day-long hearing and was the first of its kind to take place before the California legislature.
So there you have it: two weeks in the life of NORML and the NORML Foundation. Thank you for being there for us – so we can be there for you.
As we conclude this momentous year I rest assured knowing that with your continued financial contributions, NORML and the NORML Foundation will be able to maintain its position as the most trusted and respected marijuana law reform organizations in the United States. That remains our commitment to you – the cannabis consumer – as we look ahead to the success and victories that await us in 2010.
With your generous support, we are ending marijuana prohibition.With your continued generous support, we’ll end marijuana prohibition once and for all.
Cannabem liberemus,
Allen St. Pierre
Executive Director
P.S. Please make your tax-deductible donation to the NORML Foundation in support of our national outreach and educational programs.
If you’d rather your donation be employed for state and federal lobbying purposes, please make sure that the donation is directed to ‘NORML‘, where donations are not tax deductible.
#1 Obama Administration: Don’t Focus On Medical Marijuana Prosecutions
United States Deputy Attorney General David Ogden issued a memorandum to federal prosecutors in October directing them to not “focus federal resources … on individuals whose actions are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana.” The directive upheld a campaign promise by President Barack Obama, who had previously pledged that he was “not going to be using Justice Department resources to try to circumvent state laws on this issue.” Read the full story here.
#2 Public Support For Legalizing Pot Hits All-Time High
A majority of U.S. voters now support legalizing marijuana, according to a national poll of 1,004 likely voters published in December by Angus Reid. The Angus Reid Public Opinion poll results echo those of separate national polls conducted this year by Gallup, Zogby, ABC News, CBS News, Rasmussen Reports, and the California Field Poll, each of which reported greater public support for marijuana legalization than ever before. Read the full story here.
#3 Lifetime Marijuana Use Associated With Reduced Cancer Risk
The moderate long-term use of cannabis is associated with a reduced risk of head and neck cancer, according to the results of a population-based control study published in August by the journal Cancer Prevention Research. Authors reported, “After adjusting for potential confounders (including smoking and alcohol drinking), 10 to 20 years of marijuana use was associated with a significantly reduced risk of head and neck squamous cell carcinoma.” Read the full story here.
#4 AMA Calls For Review Of Marijuana’s Prohibitive Status
In November, the American Medical Association resolved that marijuana should longer be classified as a Schedule I prohibited substance. Drugs classified in Schedule I are defined as possessing “no currently accepted use in treatment in the United States.” In a separate action, the AMA also determined, “Results of short term controlled trials indicate that smoked cannabis reduces neuropathic pain, improves appetite and caloric intake especially in patients with reduced muscle mass, and may relieve spasticity and pain in patients with multiple sclerosis.” Read the full story here.
#5 California: Lawmakers Hold Historic Hearing On Marijuana Legalization
State lawmakers heard testimony in October in support of taxing and regulating the commercial production and distribution of cannabis for adults age 21 and older. Additional hearings, as well as a vote on Assembly Bill 390: the Marijuana Control, Regulation, and Education Act, are scheduled for January 12, 2010. Read the full story here.
Since 2008 more than 7,000 people, including Mexican civilians, journalists, police, and public officials, have been killed in clashes with warring drug traffickers — traffickers who US government officials allege derive 60 percent of their profits from exporting marijuana north of the border.
So what are the Obama administration’s plans to quell these gangs growing influence and the surging violence surrounding the drug trade? Troublingly, the White House appears intent on recycling the very strategies that gave rise to Mexico’s infamous drug lords in the first place.
In the December 2009 issue of The Freeman I propose another solution.
Americans’ support for legalizing the regulated production and sale of cannabis — an option that would not likely rid the world of cartels, but would arguably reduce their primary source of income — is at all an all-time high.
… Predictably, critics of marijuana legalization claim that such a strategy would do little to undermine drug traffickers’ profit margins because cartels would simply supplement their revenues by selling greater quantities of other illicit drugs. Although this scenario sounds plausible in theory, it appears to be far less likely in practice.
As noted, Mexican drug lords derive an estimated 60 to 70 percent of their illicit income from pot sales. (By comparison, only about 28 percent of their profits are derived from the distribution of cocaine, and less than 1 percent comes from trafficking methamphetamine.) It is unrealistic to think that cartels could feasibly replace this void by stepping up their sales of cocaine, methamphetamine or heroin—all of which remain far less popular among U.S. drug consumers. Just how much less? U.S. Department of Health and Human Services survey data show that roughly two million Americans use cocaine, compared to 15 million for pot. Fewer than 600,000 use methamphetamine, and fewer than 155,000 use heroin. In short, this is hardly the sort of demand that would keep Mexico’s drug barons in the lucrative lifestyle to which they’ve become accustomed.
Of course, it’s unrealistic to think that pot legalization would wipe out prohibition-inspired violence altogether. After all, ending alcohol prohibition in America didn’t single-handedly put the Mafia out of business (though it greatly reduced its power and influence). And it’s always possible that Mexico’s drug cartels would continue to engage in violent acts toward one another as competing factions fought over the crumbs of America’s drastically shrunken illicit-drug market.
That said, it’s equally unrealistic, if not more so, to think that continuing our same failed drug war policies will do anything but exponentially increase the catastrophe they’ve spawned, both in Mexico and at home. It’s time to engage in a different strategy. It’s time to seriously consider legalizing marijuana.
You are welcome to read the entire article, and provide your feedback, here.
In what can only be described as major departure in the so-called ‘war on drugs’, the Obama Administration is issuing a new three page memo this morning [Paul Armentano updates: You can now read the memorandum, signed by Deputy Attorney General David W. Ogden, here. You can also share your thoughts with the White House on the administration's decision via NORML's Take Action Center here.] mapping out the federal government’s new guidelines for states that have laws protecting medical cannabis patients.
In February Attorney General Eric Holder indicated in a press conference that the Obama Administration–which favors physician-recommended access to medical cannabis–would abate from what had been an aggressive law enforcement (and propaganda) campaign against medical access to cannabis.
Today’s memo from the Department of Justice formalizes these changes and is a MAJOR victory for citizens who support cannabis law reform!
Report: New DOJ guidelines to back medical marijuana laws
By Bridget Johnson – 10/18/09 11:40 PM ET
The Obama administration is set to make a sharp turn from the Bush administration when it comes to state laws regarding medical marijuana usage, the Associated Press reported late Sunday.
The guidelines to be issued to federal prosecutors Monday will suggest that it’s not a good use of time to go after users and distributors of medical marijuana in the 14 states that allow such usage, while encouraging that illegal pot operations involving violence, firearms and sale to minors still be pursued.
Alaska, California, Colorado, Hawaii, Maine, Maryland, Michigan, Montana, Nevada, New Mexico, Oregon, Rhode Island, Vermont and Washington currently have state laws allowing at least limited use of marijuana for medical purposes. The AP reported that federal prosecutors in these states, as well as top officials at the FBI and DEA, would being receiving the three-page Justice Department memo outlining the new policy.
Under the George W. Bush administration, medical marijuana dispensaries were still targeted for violating federal law despite state laws allowing pot for medical use. Attorney General Eric Holder signaled a shift in this policy in March, stating that federal enforcement would concentrate on illegal marijuana operations that use medical pot allowances as a cover.
The move doesn’t come as a surprise, as Obama the candidate had expressed support for states that allowed medical marijuana.
“I would not have the Justice Department prosecuting and raiding medical marijuana users,” then-Sen. Barack Obama said on the campaign trail in New Hampshire.
Two influential websites — The Hill.com’s Congress blog and the Huffington Post — have provided me with a platform to report on the contrasting impact of alcohol and cannabis on cancer.
Two just published studies assessing adults’ risk of cancer have reported wildly divergent, and fairly extraordinary, outcomes. One study you may have read about. The other has been ignored entirely by the mainstream media.
… First, the study you may have heard of. Writing August 3 in the journal Cancer Epidemiology, investigators at McGill University in Montreal reported that moderate alcohol consumption–defined as six drinks or less per week–by adults is positively associated with an elevated risk of various cancers including stomach cancer, rectal cancer, and bladder cancer.
And now for the study you haven’t heard of. Writing in the August issue of the journal Cancer Prevention Research, investigators from Rhode Island’s Brown University along with researchers at Boston University, Louisiana State University, and the University of Minnesota reported that that lifetime marijuana use is associated with a “significantly reduced risk” of head and neck squamous cell carcinoma.
As I’ve written previously, both on this blog and elsewhere, for 35 years the federal government has been well aware –- yet publicly denied –- that cannabis possesses potent anti-cancer and anti-tumor properties. Even under the Obama administration, which promised to “base [their] public policies on the soundest of science,” the myth that pot promotes cancer persists. In fact, the White House’s website, whitehousedrugpolicy.gov, presently warns, “Marijuana has the potential to promote cancer of the lungs and other parts of the respiratory tract.”
Of course, this myth persists in large part because the mainstream media rarely if ever pays attention to studies that could be seen as in any way undermining criminal prohibition. (In some cases, the MSM even goes so far as to erroneously report about those that do.) So it’s hardly surprising that in the three week span since the Brown University study was published, not one mainstream media outlet has reported its findings. (Full disclosure: over the past days I have personally communicated with several prominent newspapers’ writers about this study — in each case providing them with the full text of the investigators’ findings — but have yet to received any positive feedback beyond the obligatory “We’ll look into it.”)
Will the promotion of these findings in prominent alt-media outlets like The Hill and Huff Po reverse the MSM’s complacency? Perhaps — and your feedback to both sites can only help. So chime in (**Note: comments on both sites are moderated), and tell the MSM that it’s time for us to stop having to do their job!
Meet Hawaii’s Republican Governor Linda Lingle. On Monday, Gov. Lingle vetoedSenate Bill 1058, which called on the legislature to merely study “issues relating to medical cannabis patients and current medical cannabis laws.”
Specifically, SB 1058 called for the formation of a legislative task force to:
(1) Examine current state statutes, state administrative rules, and all county policies and procedures relating to the medical marijuana program;
(2) Examine all issues and obstacles that qualifying patients have encountered with the medical marijuana program;
(3) Examine all issue and obstacles that state and county law enforcement agencies have encountered with the medical marijuana program;
(4) Compare and contrast Hawaii’s medical marijuana program with all other state medical marijuana programs; and
(5) Address other issues and perform any other function necessary as the task force deems appropriate, relating to the medical marijuana program.
In her veto address, Gov. Lingle alleged — laughably — that the mere act of examining the medical marijuana laws of Hawaii and a dozen other statesviolates federal anti-drug laws.
“I am returning herewith, without my approval, Senate Bill No. 1058. … This bill establishes the medical cannabis task force … to review issues related to (Hawaii’s) medical marijuana program and make recommendations for any proposed legislation and rules. … The medical task force is unnecessary because it would attempt to deal with issues raised by medical marijuana users that can only be addressed by circumventing federal law.“
Keep in mind that just days earlier lawmakers in Rhode Island overwhelmingly approved legislation to allow the state to license nonprofit facilities to produce and dispense medicinal cannabis to qualified patients. Yet in Hawaii the Governor would have us believe that just gathering feedback from patients and local law enforcement regarding the state’s nearly ten-year-old medical cannabis program somehow violates federal law. It’s an absurd position and no doubt Gov. Lingle, who vetoed a similar task force bill last year, knows it.
Of course, the true motive behind Gov Lingle’s action — and the similar actions of her fellow prohibitionists — is to silence any sort of public or political debate surrounding America’s failed marijuana policies.
This was the motivation behind President Obama’s decision to ‘laugh off’ the issue of marijuana law reform during his online town hall this past March. Silencing free speech was also the driving force behind the actions of members of Congress who earlier this year threatened to withhold funding from the city of El Paso, Texas, if they so much as dared to hold an “honest, open national debate” regarding US drug policy. And surely this was the motivating force behind a South Dakota Judge’s decision this week to bar longtime NORML advocate Bob Newland from engaging in any public advocacy of marijuana law reform for one year. (Full disclosure: Bob Newland, under the banner of SoDakNORML, had been leading the petition drive to place a medical marijuana initiative on the 2010 state ballot. In other words, Judge Delaney’s decision isn’t simply limiting Mr. Newland’s constitutional rights to free speech, it’s also potentially limiting the voting rights of all South Dakotans.)
UPDATE!!! UPDATE!!! Want to make sure that your members of Congress get the message that the U.S. drug war fuels Mexican violence? Then check out my commentary today in The Hill — Congress’ insider newspaper and website. Read my commentary here, and please leave feedback on their board. Your members of Congress will see it, I promise.
To the surprise of virtually no one who has been following public opinion polls for the past 18 months, the call to “
It’s the ‘Catch-22’ that has plagued medical marijuana advocates and patients for decades. Lawmakers and health regulators demand clinical studies on the safety and efficacy of medical cannabis, but the federal agency in charge of such research bars these investigations from ever taking place.
On Monday, October 19, U.S. Deputy Attorney General David Ogden 
#1 Obama Administration: Don’t Focus On Medical Marijuana Prosecutions
Two influential websites — The Hill.com’s Congress blog and the 
Meet Hawaii’s Republican 
